User:Mr. Ibrahem/Arformoterol
 | |
 | |
| Clinical data | |
|---|---|
| Trade names | Brovana |
| Other names | Arformoterol tartrate |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a602023 |
| License data |
|
| Routes of administration | Inhalation solution for nebuliser |
| Drug class | LABA[1] |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | 52–65% |
| Elimination half-life | 26 hours |
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C19H24N2O4 |
| Molar mass | 344.411 g·mol−1 |
| |
  (what is this?) (verify) | |
Arformoterol, sold under the brand name Brovana, is a medication used for the long-term treat chronic obstructive pulmonary disease (COPD).[1] It is not indicated for sudden worsening.[2] It is given by nebulization.[1] Maximum effect may take 3 hours.[1]
Common side effects include diarrhea, sinusitis, rash, peripheral swelling, and chest pain.[1] Other side effect ma include low potassium, anaphylaxis, and bronchospasm.[1] Safety in pregnancy is unclear.[1] It is a long-acting β2 adrenoreceptor agonist (LABA).[1] It is the active component of formoterol.[1]
Arformoterol was approved for medical use in the United States in 2006.[1] It is available as a generic medication.[3] In the United States a month of medication costs about 240 USD as of 2022.[3]
References[edit]
- ^ a b c d e f g h i j k l "Arformoterol Monograph for Professionals". Drugs.com. Archived from the original on 25 January 2021. Retrieved 16 January 2022.
- ^ "DailyMed - ARFORMOTEROL TARTRATE solution". dailymed.nlm.nih.gov. Archived from the original on 16 January 2022. Retrieved 16 January 2022.
- ^ a b "Arformoterol Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 14 August 2016. Retrieved 16 January 2022.